Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain

Blood (2023) 142 (Supplement 1): 1295.

https://doi.org/10.1182/blood-2023-181541

Published: 2023

Journal Articles

Tranexamic Acid to Prevent Bleeding in Patients with Hematologic Malignancies and Severe Thrombocytopenia (TREATT trial). a Randomized Placebo-Controlled Trial

Blood (2023) 142 (Supplement 1): 702.

https://doi.org/10.1182/blood-2023-180720

Published: 2023

Journal Articles

1- and 5-Year Survival for Adults with Acute Myeloid Leukaemia and 30-Day Mortality after Initial Systemic Anti-Cancer Therapy, with an Exploration of Factors Associated with Poorer Outcomes: Data from a National Registry in England, 2013-2020

Hanhua Liu, Simon J Stanworth, Sean McMphail, Mark Bishton, Brian Rous, Andrew Bacon, Thomas Coats

Blood (2023) 142 (Supplement 1): 2846.

https://doi.org/10.1182/blood-2023-179325

Published: 2023

Journal Articles

The Pattern of Red Cell Antibodies in a Large Population of People with Sickle Cell Disease and Thalassemia

Sara Trompeter, Ana Bárbara Rodrigues Cavalcante, Marie Chion, William John Astle, Katrina Fordwor, Alexandra Pain, Nicholas Gleadall, Timothy Roberts, Jennifer Martin, Alexandra Griffiths, Willem Hendrik Ouwehand, Simon J Stanworth

Blood (2023) 142 (Supplement 1): 1289.

https://doi.org/10.1182/blood-2023-188531

Published: 2023

Journal Articles

How I diagnose and treat neonatal thrombocytopenia

Simon J. Stanworth, Andrew D. Mumford

Blood (2023) 141 (22): 2685–2697.

https://doi.org/10.1182/blood.2022018017

Published: 2023

Journal Articles

How I use platelet transfusions

Simon J. Stanworth, Akshay Shah

Blood (2022) 140 (18): 1925–1936.

https://doi.org/10.1182/blood.2022016558

Published: 2022

Journal Articles

Use of Granulocyte Transfusions in Two National Cohorts and Association between Transfusion Dose and Patient Outcomes: The Best Collaborative Study

Suzy Morton, Claire Boulat, Emma Laing, Joseph Parsons, Elisa Allen, Domenico Francis-Radice, Ruth Keogh, Jennifer A Thompson, Lorna Cain, Monica B. Pagano, Jeffrey McCullough, Pierre Tiberghien, Simon J. Stanworth

Blood (2021) 138 (Supplement 1): 3242.

https://doi.org/10.1182/blood-2021-147531

Published: 2021

Journal Articles

Low Incidence of COVID-19 Infection in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity/Venetoclax Based Treatment: Initial Results of the PACE Prospective Clinical Study from the UK Trials Acceleration Program

Blood (2021) 138 (Supplement 1): 1942.

https://doi.org/10.1182/blood-2021-146061

Published: 2021

Journal Articles

An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial

Judith C. Marsh, Simon J. Stanworth, Laura A. Pankhurst, Delordson Kallon, Adeline Z. Gilbertson, Collette Pigden, Alison J. Deary, Ana S. Mora, Joanne Brown, Emma S. Laing, Louise L. Choo, Renate Hodge, Charlotte A. Llewelyn, Kay Harding, Deborah Sage, Aleksandar Mijovic, Ghulam J. Mufti, Cristina V. Navarrete, Colin J. Brown

Blood (2021) 137 (3): 310–322.

https://doi.org/10.1182/blood.2020007199

Published: 2021

Includes: Supplemental data

Journal Articles

RBC-Enhance: A Randomized Pilot Feasibility Trial of Red Cell Transfusion Thresholds in Myelodysplastic Syndromes

Rena J. Buckstein, MD FRCPC, Anca Prica, MD, Brian Leber, MD, Nancy Heddle, MSc, Karen W.L. Yee, MD, Simon J. Stanworth, MD, David Bowen, MD, Lisa Chodirker, MD, Jennifer Gallagher, Anne Parmentier, BA, Liying Zhang, PhD, Alexandre Mamedov, Yulia Lin, MD, Jeannie L Callum, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-140165

Published: 2020

Journal Articles

Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death

Susanna F. Fustolo-Gunnink, Karin Fijnvandraat, David van Klaveren, Simon J. Stanworth, Anna Curley, Wes Onland, Ewout W. Steyerberg, Ellen de Kort, Esther J. d’Haens, Christian V. Hulzebos, Elise J. Huisman, Willem P. de Boode, Enrico Lopriore, Johanna G. van der Bom

Blood (2019) 134 (26): 2354–2360.

https://doi.org/10.1182/blood.2019000899

Published: 2019

Includes: Supplemental data

Journal Articles

Forty Percent of MDS Patients Wish They Received Red Blood Cell Transfusions at Higher Hemoglobin Thresholds Than They Currently Are: A Multinational Transfusion Audit

Rena Buckstein, MD FRCPC, Rebecca Starkman, Yulia Lin, MD FRCPC, Simon J. Stanworth, MD, David Bowen, MD PhD, Lea Harrison, Sophie Wintrich, Jeannie Callum, MD

Blood (2018) 132 (Supplement 1): 3092.

https://doi.org/10.1182/blood-2018-99-110560

Published: 2018

Journal Articles

Anemia and bleeding in thrombocytopenic patients

Jeffrey L. Carson, Simon J. Stanworth

Blood (2017) 130 (10): 1178–1179.

https://doi.org/10.1182/blood-2017-07-795922

Published: 2017

Journal Articles

Risk Factors for Bleeding: A Modelling Analysis of the TOPPS Randomized Controlled Trial of Prophylactic Platelet Transfusion

Erica M Wood, Cara Hudson, Lise Estcourt, MB BChir, FRCPath, Rachel Johnson, Simon J. Stanworth, FRCP, FRCPath, DPhil

Blood (2014) 124 (21): 1551.

https://doi.org/10.1182/blood.V124.21.1551.1551

Published: 2014

Journal Articles

Platelet transfusions for critically ill patients with thrombocytopenia

Lani Lieberman, Rachel S. Bercovitz, Naushin S. Sholapur, Nancy M. Heddle, Simon J. Stanworth, Donald M. Arnold

Blood (2014) 123 (8): 1146–1151.

https://doi.org/10.1182/blood-2013-02-435693

Published: 2014

Includes: Supplemental data

Journal Articles

The Effect of a No-Prophylactic Versus Prophylactic Platelet Transfusion Strategy On Bleeding in Patients with Hematological Malignancies and Severe Thrombocytopenia (TOPPS trial). A Randomized Controlled, Non-Inferiority Trial

Simon J. Stanworth, MRCP, FRCPath, DPhil, Lise Estcourt, MB BChir, Gillian Powter, RN, BA Health Care Studies, Brennan C. Kahan, MSc, Claire Dyer, RN, BN, Lekha Bakrania, BSc, Charlotte Llewelyn, PhD, Louise Choo, PhD, Linley Bielby, RN, MHA, Derek Norfolk, MBBS, FRCP, FRCPath, Erica M. Wood, MBBS, Michael F. Murphy, MD, FRCP, FRCPath

Blood (2012) 120 (21): 1.

https://doi.org/10.1182/blood.V120.21.1.1

Published: 2012

NARROW

Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain

Tranexamic Acid to Prevent Bleeding in Patients with Hematologic Malignancies and Severe Thrombocytopenia (TREATT trial). a Randomized Placebo-Controlled Trial

1- and 5-Year Survival for Adults with Acute Myeloid Leukaemia and 30-Day Mortality after Initial Systemic Anti-Cancer Therapy, with an Exploration of Factors Associated with Poorer Outcomes: Data from a National Registry in England, 2013-2020

The Pattern of Red Cell Antibodies in a Large Population of People with Sickle Cell Disease and Thalassemia

How I diagnose and treat neonatal thrombocytopenia

How I use platelet transfusions

Use of Granulocyte Transfusions in Two National Cohorts and Association between Transfusion Dose and Patient Outcomes: The Best Collaborative Study

Low Incidence of COVID-19 Infection in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity/Venetoclax Based Treatment: Initial Results of the PACE Prospective Clinical Study from the UK Trials Acceleration Program

An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial

RBC-Enhance: A Randomized Pilot Feasibility Trial of Red Cell Transfusion Thresholds in Myelodysplastic Syndromes

Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death

Forty Percent of MDS Patients Wish They Received Red Blood Cell Transfusions at Higher Hemoglobin Thresholds Than They Currently Are: A Multinational Transfusion Audit

Anemia and bleeding in thrombocytopenic patients

Risk Factors for Bleeding: A Modelling Analysis of the TOPPS Randomized Controlled Trial of Prophylactic Platelet Transfusion

Platelet transfusions for critically ill patients with thrombocytopenia

The Effect of a No-Prophylactic Versus Prophylactic Platelet Transfusion Strategy On Bleeding in Patients with Hematological Malignancies and Severe Thrombocytopenia (TOPPS trial). A Randomized Controlled, Non-Inferiority Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only